North China Pharmaceutical Co Ltd Free Cash Flow Generation Index
North China Pharmaceutical Co Ltd free cash flow generation index. North China Pharmaceutical Co Ltd (600812) has a Free Cash Flow Generation Index of 0.15x as of September 2025. Free cash flow of CN¥25.86 Million represents 0% of operating cash flow (CN¥170.24 Million). Check 600812 financial resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of North China Pharmaceutical Co Ltd (2000–2025)
Free cash flow generation index of North China Pharmaceutical Co Ltd from 2000 to 2025. Historical FCF Generation Index trend for North China Pharmaceutical Co Ltd across 22 annual periods. Explore North China Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
North China Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2000–2025)
North China Pharmaceutical Co Ltd free cash flow generation index by year from 2000 to 2025. Year-by-year Free Cash Flow Generation Index for North China Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of North China Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥634.53 Million | CN¥1.18 Billion | CN¥542.01 Million | ▲ +48.9% |
| 2024 | 0.36x | CN¥445.35 Million | CN¥1.23 Billion | CN¥784.22 Million | ▼ -7.5% |
| 2023 | 0.39x | CN¥401.23 Million | CN¥1.02 Billion | CN¥623.04 Million | ▼ -13.5% |
| 2022 | 0.45x | CN¥454.81 Million | CN¥1.00 Billion | CN¥549.58 Million | ▼ -5.4% |
| 2021 | 0.48x | CN¥502.75 Million | CN¥1.05 Billion | CN¥547.50 Million | ▲ +241.4% |
| 2020 | -0.34x | CN¥-254.68 Million | CN¥752.15 Million | CN¥1.01 Billion | ▼ -385.3% |
| 2019 | 0.12x | CN¥87.00 Million | CN¥732.97 Million | CN¥645.97 Million | ▼ -65.7% |
| 2018 | 0.35x | CN¥267.69 Million | CN¥774.33 Million | CN¥506.64 Million | ▲ +188.3% |
| 2017 | -0.39x | CN¥-112.44 Million | CN¥287.25 Million | CN¥399.69 Million | ▲ +80.5% |
| 2015 | -2.00x | CN¥-245.32 Million | CN¥122.50 Million | CN¥367.81 Million | ▼ -8.1% |
| 2014 | -1.85x | CN¥-167.73 Million | CN¥90.56 Million | CN¥258.30 Million | ▲ +53.6% |
| 2011 | -3.99x | CN¥-909.21 Million | CN¥227.60 Million | CN¥1.14 Billion | ▼ -726.2% |
| 2009 | 0.64x | CN¥645.03 Million | CN¥1.01 Billion | CN¥366.10 Million | ▼ -26.9% |
| 2008 | 0.87x | CN¥947.52 Million | CN¥1.09 Billion | CN¥138.00 Million | ▲ +2.4% |
| 2007 | 0.85x | CN¥566.10 Million | CN¥664.37 Million | CN¥98.27 Million | ▼ -6.7% |
| 2006 | 0.91x | CN¥545.39 Million | CN¥597.12 Million | CN¥51.72 Million | ▲ +418.3% |
| 2005 | 0.18x | CN¥39.50 Million | CN¥224.17 Million | CN¥184.67 Million | ▲ +243.5% |
| 2004 | -0.12x | CN¥-38.11 Million | CN¥310.39 Million | CN¥348.50 Million | ▼ -151.8% |
| 2003 | 0.24x | CN¥137.54 Million | CN¥580.32 Million | CN¥442.77 Million | ▼ -65.9% |
| 2002 | 0.70x | CN¥513.82 Million | CN¥738.50 Million | CN¥224.68 Million | ▲ +45.6% |
| 2001 | 0.48x | CN¥175.49 Million | CN¥367.28 Million | CN¥191.79 Million | ▲ +77.3% |
| 2000 | 0.27x | CN¥35.97 Million | CN¥133.49 Million | CN¥97.52 Million | — |